Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.
about
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented PerspectiveAdenoviral vectors for highly selective gene expression in central serotonergic neurons reveal quantal characteristics of serotonin release in the rat brain.Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialA Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male.Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion.Malignant Syndrome and Serotonin Syndrome in a General Hospital Setting: Clinical Features, Frequency and Prognosis.
P2860
Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between selective ...... euroleptic malignant syndrome.
@en
Association between selective ...... euroleptic malignant syndrome.
@nl
type
label
Association between selective ...... euroleptic malignant syndrome.
@en
Association between selective ...... euroleptic malignant syndrome.
@nl
prefLabel
Association between selective ...... euroleptic malignant syndrome.
@en
Association between selective ...... euroleptic malignant syndrome.
@nl
P2860
P356
P1476
Association between selective ...... euroleptic malignant syndrome.
@en
P2093
Debra L Stevens
P2860
P304
P356
10.1345/APH.1L066
P407
P577
2008-07-15T00:00:00Z